Searchable abstracts of presentations at key conferences in endocrinology

ea0026oc3.3 | Bone/Reproduction | ECE2011

Evolution of neurobehavioral and cognitive symptoms in patients with primary hyperparathyroidism belonging to the Swiss primary hyperparathyroidism cohort

Trombetti A , Meier C , Gold G , Torriani C , Henzen C , Herrmann F R , Christ E R , Braendle M , Kraenzlin M E , Rizzoli R

Objective: To describe the evolution of neurobehavioral and cognitive symptoms in patients with primary hyperparathyroidism as measured by mini-mental state (MMS), Hamilton’s anxiety and depression scale (HADS) and Clock tests. Scores were also compared with biochemical data.Methods: The Swiss primary hyperparathyroidism (PHPT) Cohort Study is an ongoing, prospective, non-interventional national project collecting clinical, biochemical and outcome d...

ea0029p53 | Adrenal cortex | ICEECE2012

Relationship of current glucocorticoid dose with metabolic outcomes in CAH: analysis of the United Kingdom congenital adrenal hyperplasia adult study executive (CaHASE) cohort

Han T. , Stimson R. , Rees A. , Krone N. , Willis D. , Wild S. , Conway G. , Arlt W. , Walker B. , Ross R. , CaHASE X.

We have previously reported the following metabolic abnormalities were common in 203 adult patients with CAH: obesity (41%), hypercholesterolemia (46%), insulin resistance (29%), osteopenia (40%) and osteoporosis (7%) (Arlt et al. JCEM 2010 95 5110–21). The CAH patients were taking different glucocorticoid therapies at various doses (n=196): hydrocortisone (n=25 M, 26 W), prednisolone (n=21M,67W), dexamethasone (n=15M,22W) or comb...

ea0011p387 | Diabetes, metabolism and cardiovascular | ECE2006

Androgen regulation of hepatic glucocorticoid metabolism in obese Zucker rats

Livingstone DEW , Barat P , McDonnell CR , Walker BR , Andrew R

Obesity is associated with decreased hepatic reactivation of glucocorticoids (Gc) by 11β-hydroxysteroid dehydrogenase type 1 (11HSD) and increased metabolism of glucocorticoids by hepatic A-ring reductases, which may contribute to activation of the hypothalamic-pituitary-adrenal axis. Androgen action encourages central obesity and increased metabolic complications, possibly by altering Gc metabolism.This study investigates the role of gonadal androg...

ea0010p29 | Diabetes, metabolism and cardiovascular | SFE2005

Circulating alanine aminotransferase (ALT) is elevated in obese women with PCOS, and is reduced by protracted metformin treatment

Fleming R , Harborne L , Norman J , Sattar N

Serum ALT concentrations give some insight into liver fat accumulation and relate to metabolic syndrome: values >29 IU/L double risk of type 2 diabetes independent of other risk predictors. Women with PCOS are at increased risk of diabetes and CVD whereas metformin treatment modulates the progress of metabolic syndrome. Consequently, we investigated the effects of protracted metformin treatment on circulating ALT in obese women with PCOS.Metformin tr...

ea0020p456 | Obesity and Metabolism | ECE2009

25-Hydroxyvitamin D is associated with insulin resistance, obesity, and serum lipids in polycystic ovary syndrome

Wehr Elisabeth , Pilz Stefan , Schweighofer Natascha , Giuliani Albrecht , Kopera Daisy , Pieber Thomas R , Obermayer-Pietsch Barbara

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting about 5-10% of women. PCOS is characterized by hyperandrogenism, ovulatory disturbances, and polycystic ovaries. Many women with PCOS present with insulin resistance and central obesity and are at an increased risk for developing diabetes and cardiovascular disorders. Vitamin D deficiency is an important pathogenetic factor in the development of type II diabetes. The aim of the study was to...

ea0029p850 | Endocrine tumours and neoplasia | ICEECE2012

Evaluation of beta-cell function and insulin sensitivity in a large series of insulinomas in one single tertiary centre

Furnica R. , Gigot J. , Deprez P. , Buysschaert M. , Maiter D.

Background: Patients with an insulinoma are at variable risk of severe hypoglycemia due to wide ranges of both tumoral insulin secretion and peripheral tissue sensitivity to chronic hyperinsulinaemia.Objectives: In this study we investigated the clinical, biological and tumoral characteristics of a large series of patients with immunohistochemically confirmed insulinoma and we assessed both insulin sensitivity and beta-cell function in fasting steady-sta...

ea0013p260 | Reproduction | SFEBES2007

Serum anti-mullerian hormone is elevated in girls with exaggerated adrenarche

Paterson WF , Fleming R , Ahmed SF , Wallace AM

Anti-Mullerian hormone (AMH) is produced by the ovarian granulosa cells in immature follicles from around week 36 of gestation to the menopause. Expression is highest in pre-antral and early antral follicles. AMH has a generally inhibitory effect on early follicle development and possibly on the responsiveness of growing follicles to FSH. Serum AMH is markedly elevated in women with PCOS and increased concentrations have also been reported in the healthy prepubertal daughters ...

ea0010p76 | Steroids to include Cushing's | SFE2005

Free testosterone calculation: critical comparison of three equations and establishment of reference limits

Ho C , Stoddart M , Walton M , Anderson R , Beckett G

BackgroundSerum testosterone remains the most important investigation in the diagnosis of androgen deficiency in men. Most of the circulating testosterone is bound to albumin and sex hormone binding globulin (SHBG), whereas free testosterone accounts for approximately 2% of total testosterone. Because direct measurement of free testosterone is impractical in routine practice, several equations have been used to provide clinically useful estimates of free...

ea0010dp8 | Diabetes, metabolism and cardiovascular | SFE2005

Circulating alanine aminotransferase (ALT) is elevated in obese women with PCOS, and is reduced by protracted metformin treatment

Fleming R , Harborne L , Norman a J , Sattar N

Serum ALT concentrations give some insight into liver fat accumulation and relate to metabolic syndrome: values>29 IU/L double risk of type 2 diabetes independent of other risk predictors. Women with PCOS are at increased risk of diabetes and CVD whereas metformin treatment modulates the progress of metabolic syndrome. Consequently, we investigated the effects of protracted metformin treatment on circulating ALT in obese women with PCOS.Methods<p...

ea0003p251 | Steroids | BES2002

Testosterone therapy improves depressive symptoms in men with chronic heart failure

Pugh P , Jones R , Hall J , Channer K , Jones T

Objectives: Testosterone deficiency has been associated with depressive symptoms, which may be improved by replacement therapy. Patients with chronic heart failure have a high prevalence of depression, which is associated with early mortality in these patients. Men with heart failure may also have low plasma levels of testosterone, which could contribute to depressed mood. In a clinical study investigating whether testosterone treatment benefits men with heart failure, patient...